239 related articles for article (PubMed ID: 14984418)
1. Effects of coadministration of cannabinoids and morphine on nociceptive behaviour, brain monoamines and HPA axis activity in a rat model of persistent pain.
Finn DP; Beckett SR; Roe CH; Madjd A; Fone KC; Kendall DA; Marsden CA; Chapman V
Eur J Neurosci; 2004 Feb; 19(3):678-86. PubMed ID: 14984418
[TBL] [Abstract][Full Text] [Related]
2. Biphasic nature of the effects of delta9-tetrahydrocannabinol on body temperature and brain amines of the rat.
Taylor DA; Fennessy MR
Eur J Pharmacol; 1977 Nov; 46(2):93-9. PubMed ID: 590330
[TBL] [Abstract][Full Text] [Related]
3. A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice.
Long LE; Chesworth R; Huang XF; McGregor IS; Arnold JC; Karl T
Int J Neuropsychopharmacol; 2010 Aug; 13(7):861-76. PubMed ID: 19785914
[TBL] [Abstract][Full Text] [Related]
4. Effects of Δ9-THC and cannabidiol vapor inhalation in male and female rats.
Javadi-Paydar M; Nguyen JD; Kerr TM; Grant Y; Vandewater SA; Cole M; Taffe MA
Psychopharmacology (Berl); 2018 Sep; 235(9):2541-2557. PubMed ID: 29907926
[TBL] [Abstract][Full Text] [Related]
5. The antinociceptive effect of Delta9-tetrahydrocannabinol in the arthritic rat.
Cox ML; Welch SP
Eur J Pharmacol; 2004 Jun; 493(1-3):65-74. PubMed ID: 15189765
[TBL] [Abstract][Full Text] [Related]
6. The effects of pharmacological blockade of the 5-HT(6) receptor on formalin-evoked nociceptive behaviour, locomotor activity and hypothalamo-pituitary-adrenal axis activity in rats.
Finn DP; Fone KC; Beckett SR; Baxter JA; Ansell L; Marsden CA; Chapman V
Eur J Pharmacol; 2007 Aug; 569(1-2):59-63. PubMed ID: 17599826
[TBL] [Abstract][Full Text] [Related]
7. Delta9-tetrahydrocannbinol accounts for the antinociceptive, hypothermic, and cataleptic effects of marijuana in mice.
Varvel SA; Bridgen DT; Tao Q; Thomas BF; Martin BR; Lichtman AH
J Pharmacol Exp Ther; 2005 Jul; 314(1):329-37. PubMed ID: 15831444
[TBL] [Abstract][Full Text] [Related]
8. Synergistic interaction between intrathecal ginsenosides and morphine on formalin-induced nociception in rats.
Yoon MH; Kim KS; Lee HG; Kim CM; Kim WM; Choi JI; Kim YO
J Pain; 2011 Jul; 12(7):774-81. PubMed ID: 21459679
[TBL] [Abstract][Full Text] [Related]
9. Subcutaneous administration of botulinum toxin A reduces formalin-induced pain.
Cui M; Khanijou S; Rubino J; Aoki KR
Pain; 2004 Jan; 107(1-2):125-33. PubMed ID: 14715398
[TBL] [Abstract][Full Text] [Related]
10. Functional effects of synthetic cannabinoids versus Δ
Schreiber S; Bader M; Lenchinski T; Meningher I; Rubovitch V; Katz Y; Cohen E; Gabet Y; Rotenberg M; Wolf EU; Pick CG
Addict Biol; 2019 May; 24(3):414-425. PubMed ID: 29423994
[TBL] [Abstract][Full Text] [Related]
11. Relationship between body temperature and brain monoamines during the development of tolerance to delat9-tetrahydrocannabinol in the rat.
Taylor DA; Fennessy MR
Psychopharmacology (Berl); 1978 Apr; 56(3):279-85. PubMed ID: 418435
[TBL] [Abstract][Full Text] [Related]
12. Distinct antinociceptive and conditioned behavioral effects are produced by individual cannabinoids and a cannabis-derived mixture.
Morris T; Cucinello-Ragland JA; Marks TJ; Prevost K; Glenn JF; Davenport GJ; Edwards S; Winsauer PJ
Pharmacol Biochem Behav; 2024 Feb; 235():173692. PubMed ID: 38128766
[TBL] [Abstract][Full Text] [Related]
13. Maternal exposure to delta9-tetrahydrocannabinol facilitates morphine self-administration behavior and changes regional binding to central mu opioid receptors in adult offspring female rats.
Vela G; Martín S; García-Gil L; Crespo JA; Ruiz-Gayo M; Fernández-Ruiz JJ; García-Lecumberri C; Pélaprat D; Fuentes JA; Ramos JA; Ambrosio E
Brain Res; 1998 Oct; 807(1-2):101-9. PubMed ID: 9757010
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid tetrad effects of oral Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in male and female rats: sex, dose-effects and time course evaluations.
Moore CF; Weerts EM
Psychopharmacology (Berl); 2022 May; 239(5):1397-1408. PubMed ID: 34652500
[TBL] [Abstract][Full Text] [Related]
15. The effect of delta9-tetrahydrocannabinol on body temperature and brain amine concentrations in the rat at differnt ambient temperatures.
Fennessy MR; Taylor DA
Br J Pharmacol; 1977 May; 60(1):65-71. PubMed ID: 884391
[TBL] [Abstract][Full Text] [Related]
16. A comparison of some pharmacological actions of morphine and delta9-tetrahydrocannabinol in the mouse.
Bloom AS; Dewey WL
Psychopharmacology (Berl); 1978 May; 57(3):243-8. PubMed ID: 97703
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic and behavioural profile of THC, CBD, and THC+CBD combination after pulmonary, oral, and subcutaneous administration in rats and confirmation of conversion in vivo of CBD to THC.
Hložek T; Uttl L; Kadeřábek L; Balíková M; Lhotková E; Horsley RR; Nováková P; Šíchová K; Štefková K; Tylš F; Kuchař M; Páleníček T
Eur Neuropsychopharmacol; 2017 Dec; 27(12):1223-1237. PubMed ID: 29129557
[TBL] [Abstract][Full Text] [Related]
18. Neural correlates of interactions between cannabidiol and Δ(9) -tetrahydrocannabinol in mice: implications for medical cannabis.
Todd SM; Arnold JC
Br J Pharmacol; 2016 Jan; 173(1):53-65. PubMed ID: 26377899
[TBL] [Abstract][Full Text] [Related]
19. Cannabidiol-Δ
Britch SC; Wiley JL; Yu Z; Clowers BH; Craft RM
Drug Alcohol Depend; 2017 Jun; 175():187-197. PubMed ID: 28445853
[TBL] [Abstract][Full Text] [Related]
20. Repeated treatment with cannabidiol but not Delta9-tetrahydrocannabinol has a neuroprotective effect without the development of tolerance.
Hayakawa K; Mishima K; Nozako M; Ogata A; Hazekawa M; Liu AX; Fujioka M; Abe K; Hasebe N; Egashira N; Iwasaki K; Fujiwara M
Neuropharmacology; 2007 Mar; 52(4):1079-87. PubMed ID: 17320118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
